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Abstract
Background: Population mail-out bowel screening programs are a convenient, cost-effective and sensitive method
of detecting colorectal cancer (CRC). Despite the increased survival rates associated with early detection of CRC, in
many countries, 50% or more of eligible individuals do not participate in such programs. The current study
systematically reviews interventions applied to increase fecal occult blood test (FOBT) kit return, specifically in
population mail-out programs.
Methods: Five electronic databases (PubMed, PsycINFO, Scopus, CINAHL, and ProQuest Dissertations and Theses)
were searched for articles published before the 10th of March 2018. Studies were included if they reported the
results of an intervention designed to increase the return rate of FOBT kits that had been mailed to individuals’
homes. PRISMA systematic review reporting methods were applied and each study was assessed using Cochrane’s
Risk of Bias tool. Pooled effect sizes were calculated for each intervention type and the risk of bias was tested as a
moderator for sensitivity analysis.
Results: The review identified 53 interventions from 30 published studies from which nine distinct intervention
strategy types emerged. Sensitivity analysis showed that the risk of bias marginally moderated the overall effect size.
Pooled risk ratios and confidence intervals for each intervention type revealed that telephone contact RR = 1.23, 95% CI
(1.08–1.40), GP endorsement RR = 1.19, 95% CI (1.10–1.29), simplified test procedures RR = 1.17, 95% CI (1.09–1.25), and
advance notifications RR = 1.09, 95% CI (1.07–1.11) were effective intervention strategies with small to moderate effect
sizes. Studies with a high risk of bias were removed and pooled effects remained relatively unchanged.
Conclusions: Interventions that combine program-level changes incorporating the issue of advance notification and
alternative screening tools with the involvement of primary health professionals through endorsement letters and
telephone contact should lead to increases in kit return in mail-out CRC screening programs.
Systematic review registration: This review is registered with PROSPERO; registration number CRD42017064652
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Background
Colorectal cancer (CRC) is a leading cause of morbidity
and mortality for men and women internationally, ac-
counting for 9% of all cancer incidence and 8% of all can-
cer deaths [1]. For this reason, several nations throughout
the world have implemented large-scale population CRC
screening campaigns in order to increase early detection
and thereby improve survival. One increasingly utilized
method of conducting wide-spread CRC screening is to
mail self-administered fecal occult blood test kits (hereon
FOBT) to all older (and therefore at higher risk) adults
(e.g., 50–74 year olds) with instructions for stool sample
collection and return. FOBT mail-outs are a convenient,
cost-effective, and sensitive method of increasing early de-
tection of CRC [2, 3] and participation in such programs
is associated with earlier detection and reduced CRC mor-
tality [4–7].
Unfortunately, despite the substantial increase in
CRC survival rates associated with early CRC detec-
tion, individual participation (i.e., valid and complete
kit return) remains below 50% in the majority of par-
ticipating nations including Australia, France, Czech
Republic, Germany, Latvia, and Croatia [8, 9]. For this
reason, health professionals and researchers are
experimenting with strategies to increase participation
in mail-out FOBT screening campaigns. A systematic
review of all the interventions that have been imple-
mented to increase FOBT kit return, specifically in
population mail-out screening programs, has not been
reported. This study aims to determine which inter-
ventions are most supported in the literature and
which have the largest effects. To do this, the current
study systematically reviews all published studies
where interventions have been applied to mail-out
FOBT kits and kit return has been reported as an
outcome.
Method
Search strategy
A systematic review was conducted to identify studies (pub-
lished before the 10th of March 2018) in which an interven-
tion to increase participation in a mail-out FOBT-based
CRC screening program was assessed. The review method-
ology followed the PRISMA statement for the conduct and
reporting of systematic reviews [10] (Fig. 1 contains
PRISMA flow chart and PRISMA checklist is available as
Additional file 1). The review protocol was registered with
International Prospective Register of Systematic Reviews
(PROSPERO); registration number CRD42017064652. Five
electronic databases, PubMed, PsycINFO, Scopus, CINAHL,
and ProQuest Dissertations and Theses A & I, and Google
Scholar were searched using title, abstract, and keyword
Fig. 1 PRISMA flow chart of search and filter results
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searches for terms such as “fecal (and faecal) occult blood,”
“FOBT,” “uptake,” “participation,” and “compliance” (see
Additional file 2 for precise syntax). The initial database
search was conducted on 6 March 2017 by the first author.
Hand searches for relevant articles were also conducted,
through ancestral searching of the reference lists of included
articles, as well as searching included articles in Google
Scholar and using the “cited by” function. This exact search
strategy was replicated by a second independent reviewer
between the 17th and 31st of May 2017 with no new articles
identified. The search was replicated a third time by a third
reviewer (LM) between the 10th and 24th of March 2018 to
ensure our results were as up to date as possible before pub-
lication, and two further studies eligible for inclusion were
identified in this final search [16.45]. The search results de-
tailed in the systematic review findings and the PRISMA
flow chart in Fig. 1 reflect this latest search.
Study selection
To be included in the current review, articles needed to
involve the implementation of a strategy to increase the
return rate of FOBT kits in a postal CRC screening pro-
gram. Only quantitative studies where the outcome vari-
able was the return of FOBT kits were included. Articles
were excluded if test kits were voluntarily requested, not
routinely mailed to participants, where the return of
FOBT kits was not reported separately from other
methods of CRC screening, or if the data had been re-
ported in another study already included in the review.
Review articles, conference abstracts, and articles not
available in the English language were also excluded.
Full-text screening of potentially relevant articles was
carried out using these criteria. As with the searches, an
independent reviewer replicated this study selection
protocol in May 2017 and a third reviewer (LM) con-
ducted the study selection protocol again on the updated
search results in March 2018. The results pertaining to
the study selection detailed in the systematic review
findings and the PRISMA flow chart in Fig. 1 reflect the
latest search.
Analysis
Summary data was extracted for each intervention, includ-
ing author, sample size, age and country of participants,
intervention type, comparison group, and key findings.
These are presented in Additional file 3. Unadjusted risk
ratios (RR) and 95% confidence intervals (CI) for each
intervention were calculated using raw, intention to treat
(where available), uptake data provided within each article.
The Cochrane Risk of Bias tool [11] was applied to each
study by the first author, with outcomes replicated by an
independent reviewer without discrepancy. Sources of bias
such including, randomization, allocation, blinding, in-
complete outcome data, and selective reporting were
graded as low, high risk, or unclear for each study. Studies
with at least one element assessed as high risk were rated
as “high risk of bias” and studies with two or more ele-
ments assessed as unclear were rated as “unclear risk of
bias,” while the remainder of studies were rated as “low
risk of bias.” A total pooled effect size was calculated with
the risk of bias as a moderator for a sensitivity analysis.
Pooled effect sizes (RR) and 95% CIs are presented and
compared for each intervention category with three or
more studies. Data analysis was conducted in R using the
Metafor package [12, 13]. Heterogeneity was assessed by
calculating I2 values. Due to variations in populations and
implementation of interventions within each category,
random effects models with restricted maximum likeli-
hood estimation were utilized [14, 15]. Publication bias
(and other small study effects) was assessed quantitatively
via inspection of funnel plots and consulting Egger’s re-
gression test for funnel plot asymmetry.
Results
Systematic review
As detailed in Fig. 1, 3213 records were identified in the
initial search. After duplicates were removed, records
were screened for relevance first by reviewing titles and
abstracts, leaving 111 articles. This included an add-
itional 10 records that were identified through hand
searches during this process. From this, 81 articles were
excluded based on the inclusion-exclusion criteria de-
scribed above, leaving 30 for inclusion in the current
systematic review. Study origins, dates, designs, effect
sizes, and conclusions from 59 interventions within the
30 studies reviewed are detailed in the data extraction
table Additional file 3. These studies originated from 10
different countries including Australia (n = 7), UK
(Scotland, North Ireland, Wales, and England; n = 13),
USA (n = 3), Netherlands (n = 4), Israel (n = 1), Spain
(n = 1), and Latvia (n = 1). Sample sizes for each inter-
vention ranged from 153 to 1,167,017 (median = 5000).
As detailed in Table 1, nine distinct intervention types
were identified based on the strategies they employed.
Risk of bias
As detailed in Table 2, studies were largely rated as hav-
ing a low risk of bias (n = 29). Ten studies had an un-
clear risk of bias and four studies had a high risk of bias.
Sixteen of the studies reviewed did not provide details
within the manuscript regarding whether efforts were
made to blind research personnel or participants to
group allocation, and 1 study indicated that blinding of
personal and participants did not occur. Ten studies
neglected to report whether the group allocation process
was concealed from research personnel and two studies
indicated this did not occur. In 12 studies, it was unclear
whether selective reporting had occurred as a clear
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outcome variable was not defined (e.g., whether partici-
pation was measured on an “intention to treat basis”).
Eight studies did not describe the procedure for random
allocation, while two studies indicated that participants
were not randomly allocated to the intervention group.
In terms of the separate interventions, 11 interventions
came from high risk of bias studies, 22 from unclear risk
studies, and 26 from low-risk studies. Risk of bias within
each intervention type is reported within the systematic
review findings and tabled in Additional file 3.
GP endorsement
Twelve interventions reported across six studies [16, 17,
27, 44, 46, 47] from Australia and the UK utilized GP
endorsement. Eight of the interventions were from high
risk of bias studies and four were from low-risk studies.
Eight of these interventions were from two studies that
trialed two interventions at four time points on the same
sample (accounting for the large proportion of high risk
of bias interventions in this group). Eight interventions
tested the effect of an endorsement letter personally
signed by the participant’s GP, all of which were signifi-
cantly effective in increasing screening uptake with effect
sizes ranging from RR = 1.01 (CI = 1.01–1.02) to RR =
2.19 (CI = 1.67–2.87). The remaining interventions
tested the effectiveness of including a letter from the GP
practice (rather than from the specific GP) over four
time points, showing a statistically significant positive
effect on uptake at the first RR = 1.27 (CI = 1.12–1.44)
and fourth RR = 1.19 (CI = 1.04–1.37) time point.
Behavior priming
Six interventions from five studies in Australia, UK,
Israel, and the USA utilized behavior priming as an
intervention strategy [18, 30, 33, 35, 48]. Two inter-
ventions were from low risk of bias studies and four
were from the unclear risk of bias studies. Only one
intervention, using an intention implementation
technique, resulted in a significant increase in uptake
of screening, RR = 1.05 (CI = 1.04–1.07). In this inter-
vention, prewritten if-then statements regarding
when, where, and how to take the test were included
with the FOBT kit [48]. Interventions utilizing prim-
ing techniques such as advocacy from other people,
information on risks, and the priming of anticipated
regret did not yield significant effects.
Print materials
Eleven interventions from nine studies across Australia, the
UK, and the USA added printed content to the screening
kit [29, 31, 33, 35, 42, 43, 46, 47, 49]. Three of the interven-
tions came from studies with an unclear risk and the re-
mainder was from low-risk studies. One intervention that
issued a leaflet with enhanced “easy to read” instructions
and a CRC educational component showed a small signifi-
cant increase in kit return [46], RR = 1.12 (CI = 1.01–1.23).
Another issuing an enhanced reminder letter [47] had a
Table 1 Types of interventions
Category n Description
Behavior priming 6 Where the text content within printed
materials accompanying a kit were
manipulated to prime or encourage
screening behavior (e.g., priming regret,
implying advocacy from others, setting intentions).
Added print materials 11 Where extra information in print format was
added to the standard kit (e.g., educational
booklets on CRC, or enhanced instructions).
Incentive 1 Where participants were offered an incentive
to return completed kits.
Advance notification 4 Where letters notifying participants of the kit
arrival were sent out prior to the kit.
Outdoor advertising 1 The placement of billboards or posters in
public areas.
Simplified test 17 Where the FOB testing procedure itself was
simplified or enhanced for the user
(e.g., removing dietary restrictions or including
collection papers).
Telephone contact 4 Where participants were contacted by telephone
for the reminder and/or instruction purposes.
GP endorsement 6 Where the kit invitation included a letter from
the participant’s GP or GP practice.
Digital reminder 3 Where participants are sent either an SMS or email
reminder to complete and return FOBT kit
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very weak significant positive effect of uptake, RR = 1.03
(CI = 1.01–1.05). Of the five interventions that involved
sending CRC information booklets with kits, none showed
a significant effect on uptake. Two interventions that in-
cluded surveys into the invitation packs had no significant
effect on uptake [35, 42] and the inclusion of narrative
leaflets (n = 2) were associated with very small decreases in
participation [31, 42].
Simplified test procedures
Seventeen interventions from 12 different studies based
in Australia, Netherlands, the UK, Latvia, and Spain
Table 2 Cochrane Collaboration tool for assessing risk of bias
First author and
year
Random
sequence
generation
Allocation
concealment
Blinding of
participants
and personal
Blinding of
outcome
assessment
Incomplete
outcome data
Selective
reporting
Other
bias
Overall
Risk of Bias
Benton et al. [16] H H H L L L L H
Cole et al. [17] L L U L L L L L
Cole et al. [18] L L L L L L L L
Cole et al. [19] U U U L U L U U
Corondado et al. [20] L U U L L L L L#
Denters et al. [21] L L U U L U U U
Deutekom et al. [22] L L L U L L L L
Gupta et al. [23] L L L L L L L L
Hewitson et al. [24] L L L L L L L L
Hirst et al. [25] L L L L L U L L
Hughes et al. [26] H H U U H U H H
King et al. [27] U U U L L U H H
King et al. [28] U U U L L U L U
Libby et al. [29] L L L L U L L L
Lo et al. [30] L U U L L U L U
McGregor et al. [31] U L L L L L L L
Moss et al. [32] L L U L L L L L
Myers et al. [33] U U L L U L L U
Neter et al. [34] L L U L L L L L
O'Carroll et al. [35] L L U L L L L L
Robinson et al. [36] U U U L L U L U
Santare et al. [37] L L U U L U L U
van Roon, [38] L L U L U U L U
van Rossum et al. [39] L L L U L L L L
Verne et al. [40] U U L U L U U U^
Wardle et al. [41] (1) L L L L L L L L
Wardle et al. [41] (2) L L L L L L L L
Wardle et al. [41] (3) L L L L L L L L
Wardle et al. [41] (4) L L L L L U U L
Watson et al. [42] L U U L L L L L
White et al. [43] U U U L L L L U*
Zajac et al. [44] L L L U L L H H¥
Zubero et al. [45] L L L L L U L L
L = low, U = unclear, H = high
#Risk of bias is high for the email intervention as not randomly assigned
^Risk of bias is suggested to be high for the self- versus lab-analyzed stool sample intervention as it is much less likely that participants would return self-
analyzed negative results
*Risk of bias is suggested to be high for the outdoor advertising intervention implemented in White et al. 2015 because participants not randomly allocated
¥Zajac et al., 2010 reports on the same sample as Cole et al., 2007 and was therefore deemed high risk of bias
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involved simplifying test procedures [18, 21, 22, 26, 36,
37, 39, 40, 43, 45, 50]. Two of the interventions were
from high-risk studies, nine were from studies with an
unclear risk of bias, and six were from low-risk studies.
The provision of an immunochemical (FIT) rather than
a guaiac (gFOBT)-based test kit (usually involving fewer
stool samples and/or the removal dietary restrictions)
had a significant positive effect in all five trials, with ef-
fect sizes ranging from RR = 1.12 (CI = 1.11–1.13) to
RR = 1.48 (CI = 1.41–1.55). Of the three interventions,
that only removed dietary restrictions from kit instruc-
tions, two showed significant positive effects on uptake
[18, 36] RR = 1.42 (CI = 1.09–1.83) and RR = 1.50 (CI =
1.27–1.76), whereas the other showed no significant ef-
fect [40]. Interventions that involved enclosing gloves
with the stool collection kit [43] or providing a poten-
tially superior brand of FIT kit [18, 37, 45] also yielded
significant positive effects on kit return with effect sizes
ranging from RR = 1.05 (CI = 1.01–1.10) to RR = 1.47
(CI = 1.28–1.68). Interventions that did not have signifi-
cant positive effects on uptake included the issue of a
kit where samples were self-analyzed at home and those
where stools sample was collected using a or feces col-
lection paper [21, 40].
Telephone contact
Of the four interventions that applied telephone contact
strategies (two each from two USA-based studies, one
unclear and one low risk of bias) [33, 51], three reported
significant positive effects on uptake with effect sizes
ranging from RR = 1.29 (CI = 1.12–1.49) to RR = 1.34
(CI = 1.13–1.60). These three studies included two live
30-day reminder telephone call interventions [33, 52]
and one intervention where kit recipients received an in-
struction call to assist with completing the kit [33]. The
telephone intervention that had no effect on uptake in-
volved an automatic reminder phone call [51].
Advance notification
Four interventions from four studies based in Australia,
the UK, Latvia, and the Netherlands, issued advance noti-
fication letters to participants approximately 2 weeks prior
to sending the invitation and FOBT kit [19, 29, 37, 38].
Two interventions from studies with an unclear risk of
bias and two were rated as low. All had a significant posi-
tive effect on the uptake, with effect sizes ranging from
RR = 1.06 (CI = 1.01–1.11) to RR = 1.22 (CI = 1.08–1.39).
Digital reminders
Three interventions utilizing digital reminders from two
studies in the UK and the USA were identified where text
messages or emails were sent to participants [51, 53].
None of these interventions were successful in signifi-
cantly increasing participation. The two interventions
utilizing text messages came from studies with a low risk
of bias, whereas the email intervention was rated as a high
risk of bias intervention due to non-random group alloca-
tion. Interventions using text messages did not show sig-
nificant negative effects overall, but in a sub-sample of
previous non-responders, a text message from a GP was
associated with a significant increase in program uptake in
one study [53] RR = 1.16 (CI = 1.02–1.32).
Other interventions
One intervention from a low risk of bias USA study of-
fering small ($5–$10) monetary incentives to partici-
pants [23] did not report a significant increase in
screening uptake, and one high risk of bias campaign in-
volving outdoor advertising, posters, and GP and adverts
on pharmacy bags [43] had a significant positive effect
on uptake RR = 1.08 (CI = 1.05–1.14).
Meta-analysis
Pooled effect sizes for each intervention type (excluding
those with only one intervention) were calculated and
presented in Figs. 2 and 3. When pooled effect sizes for
each intervention type were compared, telephone con-
tact RR = 1.23 (1.08–1.40) was associated with the high-
est increase in uptake, followed by GP endorsement
RR = 1.19 (1.10–1.29), simplified test procedures RR =
1.17 (1.09–1.25), and advance notification RR = 1.09
(1.07–1.11). This translates to approximately 5 to 7%
more kits being returned kits in intervention groups
compared to reference groups. Forest plots for each
intervention type are provided in Additional file 4.
Sensitivity analysis
The moderation effect of risk of bias was marginal (Q
(2) = 5.54, p = .06) with interventions from the high risk
of bias studies yielding a slightly higher effect RR = 1.20
(CI = 1.11–1.30) than interventions low-risk studies RR =
1.08. (CI = 1.03–1.13). The pooled RR of interventions
from unclear studies RR = 1.08 (1.02–1.14) did not differ
significantly from interventions from high or low-risk
studies. The moderation effect of type of intervention
was significant Q (9) = 78.41, p = .001. Interventions from
studies with a high risk of bias were removed and pooled
effects for each intervention type were recalculated.
These effect sizes were almost identical, with the key ex-
ception that the pooled estimate for GP endorsement
decreases to RR = 1.12 (1.02–1.24). Separate plots for
each intervention type can be found in Additional file 4.
Post hoc meta-analysis including only these four inter-
vention types showed that intervention type was not a
significant moderator of effect size QM (3) = 1.46, p =
0.70, suggesting they are statistically, equally effective.
Pooled effects of behavior priming RR = 1.00 (0.96–1.04)
digital reminders RR = 0.94 (0.83–1.08), and print
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materials RR = 0.99 (0.97–1.01) were not significantly
different from zero.
Heterogeneity
Without moderators in the model, heterogeneity was high,
with 97.2% of dispersion attributable to between-study dif-
ferences. Heterogeneity remained high within each risk of
bias group, I2high = 80.01%, I
2
unclear = 98.54%, I
2
low = 93.14%.
Heterogeneity levels varied widely between intervention
types, ranging from I2 = 98.5% and I2 = 95.6% for simplified
test procedures and GP endorsement respectively to I2 =
1.1% for advance notifications. Added print materials and
behavioral priming both had I2 values of 85.5% while tele-
phone contact and digital reminders were I2 = 61.5% and
I2 = 53.9% respectively.
Publication bias
There was marginal evidence of publication bias t (57) =
2.07, df = 57, p = 0.04. The King et al. 1992 study trialing
a GP endorsement was an outlier in terms of effect size
(RR–2.19) and standard error (low). With this influence
removed, publication bias decreased significantly t
(56) = 1.94, p = 0.06. Publication bias within each inter-
vention type was not evident (all ps < .05) except for GP
endorsement t (10) = 6.07, p < .01. This was also likely
due to the influence of the King et al. 1992 study. Pooled
effect sizes from GP endorsement were presented with
and without this intervention which also had a high risk
of biased results according to the Cochrane Risk of Bias
evaluation.
Discussion
Several effective intervention strategies for increasing kit
return in mail-out, population-based FOBT programs
were identified through this systematic review and meta-
analysis. The evidence reviewed here provided support
for the use of four key intervention strategies including
advance notification, GP endorsement, telephone con-
tact, and the simplification of testing procedures. These
findings have implications for both policy change and
practical program changes that may increase future up-
take in population mail-out CRC screening campaigns.
Although there were no statistically significant differ-
ences in effectiveness between the four key identified
strategies, interventions involving telephone contact
were associated with the highest average increase in the
rate of kit. Limited studies (n = 2) have trialed the use of
telephone contact as an intervention strategy; however,
the available evidence suggests that live phone calls with
kit recipients are associated with the higher kit return.
Automated phone calls, where the recipient is played a
recorded message, are not [52]. Interestingly, other
forms of automated contact such as email and text mes-
sage reminders were also unsuccessful, in one instance
leading to decreased participation [52], suggesting that
human interaction might be key to the effectiveness of
personal reminders.
GP endorsement is a well-researched intervention
strategy in terms of both the amount and consistency of
evidence available, providing sound justification for its
application in future CRC screening initiatives. Even
when interventions from studies with high risk of bias
were ignored, the inclusion of GP endorsement letter
with the FOBT kit was associated with a modest, but sig-
nificant, increase in kit return. These findings are not
surprising considering GP information is the most fre-
quently sought and trusted source of medical advice for
most people [54–56] and the demonstrated positive ef-
fect of GP involvement in increasing cancer screening in
general [57].
According to the current review, telephone contact
and GP endorsement are both promising strategies for
Fig. 2 Pooled risk ratio estimates and 95% confidence intervals for each intervention type (interventions from high risk of bias studies included)
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increasing FOBT kit return, however, the underlying rea-
sons for their success remain unknown. For example,
GP endorsement may be effective due to the participant
having a personal (i.e., face-to-face connection) with
their GP, the respect they have for their GP, or due to
the letter being personally signed by someone. In the
current review, interventions where letters were signed
by the GP (as opposed to the GP practice more broadly)
demonstrated higher and more consistent positive ef-
fects on kit return. In conjunction with the finding that
live telephone calls were more effective than automated
reminders, this suggests that a key element of interven-
tion success may be a personal or proximal connection
with the sender/caller. However, the effectiveness of
these strategies may also be moderated by factors such
as participant trust in the organization contacting them
or the degree to which they generally adhere to advice
from health professionals. Studies reviewed here that re-
ported on the effects of GP endorsement were con-
ducted in communities where general practice is a
strong component of the health system. In settings
where this is not the case, the effectiveness of GP en-
dorsement would likely be less, and endorsement of
CRC screening may be more effective coming from
other respected sources of health advice. Future qualita-
tive and experimental research can help draw conclu-
sions about the mechanisms through which GP
endorsement and telephone contact might be effective
as well as the context in which these strategies will be
most successful.
Simplification of the testing procedure also tended to
be associated with the increased kit return. Hesitation or
refusal to partake in CRC screening has been associated
with reactions of disgust at the thought of stool manipu-
lation [58]. Interestingly, however, interventions where
extra or modified materials were supplied to assist with
stool collection and limit contact (e.g., including stool
collection wipes or collection papers) were generally not
effective. Instead, interventions that reduced the number
of steps or the effort required to take the test were more
often associated with kit completion and return. For ex-
ample, the removal of dietary restrictions and issue of
immunochemical-based (FIT; 2 sample, with no diet re-
striction) rather than guaiac-based (gFOBT; 3 sample,
with diet restrictions) kits tended to be most consistently
effective in increasing kit return and with the largest
effects.
Providing participants with advance notification before
sending the kit—a practice already standard in many pro-
grams—had a consistent, but small effect across the four
trials reviewed. Agencies not already issuing advance noti-
fications to potential participants may see modest in-
creases in participation by adopting this method.
Studies that assessed the use of print materials and be-
havior priming techniques were generally unsuccessful,
suggesting the actual content of the printed materials ac-
companying kits appeared to have less impact on uptake
than the source of the content (i.e., GP signed). Strat-
egies that involved adding extra print materials to FOBT
kits were largely unsuccessful in encouraging participa-
tion. In fact, the inclusion of a narrative information
leaflet had a negative effect on kit return in two separate
studies, suggesting that excessive information may bur-
den and deter, rather than encourage, participation. The
manipulation of text within print materials to prime
screening behavior was also, for the most part, unsuc-
cessful. However, only a small group of behavior priming
strategies have been trialed. These include highlighting
the negative consequences of inaction, intention imple-
mentation, and advocacy from others. There is still
Fig. 3 Pooled risk ratio estimates and 95% confidence intervals for each intervention type (interventions from high risk of bias studies
not included)
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scope for research into different types of behavior prim-
ing interventions and definitive conclusions cannot yet
be drawn about the effectiveness of this type of interven-
tion strategy broadly. Nevertheless, according to the evi-
dence reviewed, adding or manipulating printed content
has not been supported as a successful intervention
strategy.
Other intervention types were underrepresented in the
available literature and consequently, the degree to
which they are effective is unknown. Our understanding
of the effectiveness of outdoor advertising may be
strengthened in the future by implementing better con-
trolled experimental designs. Intriguingly, offering a
monetary incentive did not show promising results in
the current review. No studies examined the use of so-
cial media or media campaigns.
Policy and practical implications
Given that mail-out FOBT screening campaigns tend to
be population-wide, government-driven initiatives, the
current findings have several policy-level implications. For
example, the FIT has been adopted by the majority of
screening programs internationally; however, programs in
some countries including Croatia, Finland, Portugal, and
China still distribute the traditional gFOBT kits [9, 59].
Policy-makers in these nations may see a rise in CRC
screening and detection rates should they adopt the FIT
as their standard screening tool [8, 59]. Similarly, incorp-
orating advance notification as part of the standard proto-
col for kit distribution should result in small increases in
uptake. The current review suggests that resources spent
on designing and distributing extra print materials with
FOBT kits might be more effectively spent on other inter-
vention methods.
Interventions that involve GPs or other professional
endorsement of screening can be affected at a practical
level. For example, health professionals and organiza-
tions may be able to contribute to increased uptake in
CRC screening by contacting patients eligible to receive
kits by phone, mail, or in person to encourage screening
and provide support during the testing process.
Ultimately, an intervention that combines program-
level changes and the involvement of primary health ser-
vices may potentially have the most positive effect on
uptake. For example, substantial increases in participa-
tion could result if kit simplification and endorsement
strategies are combined, increasing both intentions to
screen and the time and resources one has to complete
the test. However, the additive benefits of such ap-
proaches have not yet been empirically tested.
Strengths and limitations
This systematic review is the first to focus specifically on
methods of increasing uptake in CRC screening via
mail-out FOBTs, providing up to date and rigorously ob-
tain information regarding the most effective interven-
tions specific to this form of a public health initiative.
However, some limitations apply. Although a compre-
hensive list of relevant databases was searched, the list
was not exhaustive and more articles may have been
identified if other databases such as Embase or CEN-
TRAL were included. Heterogeneity across interventions
was high even within categories; likely reflecting varying
methodologies applied in each. It is also important to
note that I2 values are susceptible to over-estimation in
large sample sizes and therefore must be interpreted
with caution [60]. Nevertheless in the future, when more
interventions have been published, researchers may be
able to categorize them into more homogenous groups
in order to identify the most effective delivery of each
specific type of intervention. Although the majority of
studies reviewed were rated as having a low risk of bias,
a large proportion of interventions came from studies
with unclear or high risk of bias. Although the risk of
bias had minimal effect on effect sizes, readers are cau-
tioned to consider this, particularly when interpreting
the pooled effect of GP endorsement which decreased
when interventions from studies with high risk of bias
were removed.
Conclusion
Findings from the current review suggest that GP en-
dorsement, telephone interaction, advance notification,
and the issue of FIT over gFOBT kits are promising strat-
egies for increasing uptake in mail-out screening pro-
grams. Further research is needed to understand the
mechanisms underlying the success of these interventions
and how they might be applied in different settings.
Nevertheless, government and health organizations aiming
to increase the general population uptake of FOBT
screening for CRC will likely benefit from incorporating
these strategies into future interventions. Lastly, it is im-
portant to note that the potential increases in uptake from
current intervention strategies are modest. Novel or com-
bined approaches to encourage CRC screening may be re-
quired if population-wide compliance is to be achieved.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13643-019-1170-x.
Additional file 1. Contains the PRISMA checklist.
Additional file 2. Contains each search syntax entered for each
database/source.
Additional file 3. Contains full table of extracted data from each study
including author, date, sample size, age and country of participants,
intervention type, comparison group, key findings and risk of bias.
Goodwin et al. Systematic Reviews           (2019) 8:257 Page 9 of 11
Additional file 4. Contains a forest plot for each meta-analysis con-
ducted on each intervention type (including those with interventions
from high risk of bias studies included and excluded).
Abbreviations
CI: Confidence interval; CRC: Colorectal cancer; FIT: Fecal immunochemical
test; FOBT: Fecal occult blood test; gFOBT: Guaiac-based fecal occult blood
test; GP: General practitioner; RR: Risk ratio
Authors’ contributions
BCG conducted the search, analysis and drafted the manuscript. MJI was
involved in the initial planning and conceptualization of the review and
assisted with meta-analysis and manuscript review. SM was involved in the
initial planning and conceptualization of the review and contributed substan-
tial content throughout the manuscript. LM conducted the bulk of meta-
analysis and wrote parts of the results section. FCW assisted in the literature
search, conducted the second review risk of bias review, and contributed
substantial content throughout the manuscript. SKC was involved in the ini-
tial planning and conceptualization of the review and contributed to content
regarding the interpretation and implication of findings. JA was involved in
the initial planning and conceptualization of the review and contributed ad-
vice regarding manuscript content. JD was involved in the initial planning
and conceptualization of the review and contributed to content regarding
the interpretation and implication of findings. All authors read and approved
the final manuscript.
Funding
This research was jointly funded by the University of Southern Queensland
and Cancer Council Queensland.
Availability of data and materials
Kit return data extracted from articles used in meta-analysis available on re-
quest from the corresponding author.
Ethics approval and consent to participate
Not applicable
Consent for publication
Not applicable
Competing interests
The authors declare that they have no competing interests.
Author details
1Institute for Resilient Regions, University of Southern Queensland,
Springfield Central, QLD 4300, Australia. 2School of Psychology and
Counselling, University of Southern Queensland, Springfield Central, QLD,
Australia. 3Cancer Research Centre, Cancer Council Queensland, Fortitude
Valley, QLD, Australia. 4Faculty of Health, University of Technology Sydney,
Sydney, Australia. 5Prostate Cancer Foundation of Australia, St Leonards,
NSW, Australia. 6Menzies Health Institute, Griffith University, Southport, QLD,
Australia. 7School of Public Health and Social Work, Queensland University of
Technology, Brisbane, QLD, Australia. 8Menzies Health Institute Queensland,
Griffith University, Brisbane, QLD, Australia. 9School of Social Science,
University of Queensland, Brisbane, QLD, Australia. 10School of Medicine,
Griffith University, Brisbane, QLD, Australia.
Received: 10 July 2018 Accepted: 27 September 2019
References
1. Parkin D, et al. World Health Organization cancer incidence in five
continents Lyon. World Health OrganInt Agency Res Cancer. 2002;8:1–771.
2. Government A. In: D.o.H.a. Aging, editor. The Austalian Bowel Cancer
Screening Pilot Program and Beyond: Final Evaluation Report. ACT, Australia:
Commonwealth of Australia; 2005.
3. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening
for colorectal cancer in the general population. JAMA. 2000;284(15):1954–61.
4. Kronborg O, et al. Randomized study of biennial screening with a faecal
occult blood test: results after nine screening rounds. Scand J Gastroenterol.
2004;39(9):846–51.
5. Scholefield J, et al. Nottingham trial of faecal occult blood testing for
colorectal cancer: a 20-year follow-up. Gut. 2011; p. gutjnl-2011-300774.
6. Ananda S, et al. Survival impact of the Australian National Bowel Cancer
Screening Programme. Intern Med J. 2016;46(2):166–71.
7. Australian Institue of Health and Welfare. Analysis of bowel cancer
outcomes for the National Bowel Cancer Screening Program. Australian
Government, Canberra; 2014. Report No.: Cat. no. CAN 87.
8. Navarro M, et al. Colorectal cancer population screening programs
worldwide in 2016: an update. World J Gastroenterol. 2017;23(20):3632.
9. Swan H, Siddiqui AA, Myers RE. International colorectal cancer screening
programs: population contact strategies, testing methods and screening
rates. Pract Gastroenterol. 2012;36(8):20–9.
10. Liberati A, et al. The PRISMA statement for reporting systematic reviews and
meta-analyses of studies that evaluate health care interventions: explanation
and elaboration. PLoS Med. 2009;6(7):e1000100.
11. Higgins JP, et al. The Cochrane Collaboration’s tool for assessing risk of bias
in randomised trials. BMJ. 2011;343:d5928.
12. Team RC. R: A language and environment for statistical computing. Vienna:
Foundation for Statistical Computing; 2017.
13. Viechtbauer W. Conducting meta-analyses in R with the metafor package. J
Stat Softw. 2010;36(3):1–48.
14. Viechtbauer W. Bias and efficiency of meta-analytic variance estimators in
the random-effects model. J Educ Behav Stat. 2005;30(3):261–93.
15. Michael Borenstein, Hedges LV, Julian P. T. Higgins, Hannah R. Rothstein,
Introduction to Meta-Analysis. 2009, United Kingdom: Wiley.
16. Benton SC, et al. GP participation in increasing uptake in a national bowel cancer
screening programme: the PEARL project. Br J Cancer. 2017;116(12):1551.
17. Cole SR, et al. Participation in screening for colorectal cancer based on a
faecal occult blood test is improved by endorsement by the primary care
practitioner. J Med Screen. 2002;9(4):147–52.
18. Cole SR, et al. A randomised trial of the impact of new faecal haemoglobin
test technologies on population participation in screening for colorectal
cancer. J Med Screen. 2003;10(3):117–22.
19. Cole SR, et al. An advance notification letter increases participation in
colorectal cancer screening. J Med Screen. 2007;14(2):73–5.
20. Coronado GD, Rivelli JS, Fuoco MJ, Vollmer WM, Petrik AF, Keast E, et al.
Effect of reminding patients to complete fecal immunochemical testing: A
comparative effectiveness study of automated and live approaches. J Gen
Intern Med. 2018;33(1):72–8.
21. Denters MJ, et al. A feces collection paper does not enhance participation
in a fecal immunochemical test-based colorectal cancer screening program:
randomized clinical trial. Eur J Cancer Prev. 2013;22(4):299–304.
22. Deutekom M, et al. Comparison of guaiac and immunological fecal occult
blood tests in colorectal cancer screening: the patient perspective. Scand J
Gastroenterol. 2010;45(11):1345–9.
23. Gupta S, et al. Financial incentives for promoting colorectal cancer
screening: a randomized, comparative effectiveness trial. Am J
Gastroenterol. 2016;111(11):1630–6.
24. Hewitson P, Ward AM, Heneghan C, Halloran SP, Mant D. Primary care
endorsement letter and a patient leaflet to improve participation in
colorectal cancer screening: Results of a factorial randomised trial. Br J
Cancer. 2011;105(4):475–80.
25. Hirst Y, Skrobanski H, Kerrison RS, Kobayashi LC, Counsell N, Djedovic N, et
al. Text-message Reminders in Colorectal Cancer Screening (TRICCS): A
randomised controlled trial. Br J Cancer. 2017;116(11):1408–14.
26. Hughes K, et al. Guaiac versus immunochemical tests: faecal occult blood
test screening for colorectal cancer in a rural community. Aust N Z J Public
Health. 2005;29(4):358–64.
27. King J, et al. Colorectal cancer screening: optimal compliance with postal
faecal occult blood test. Aust N Z J Surg. 1992;62(9):714–9.
28. King J, Fairbrother G, Thompson C, Morris DL. Influence of socioeconomic
status, ethnicity and an educational brochure on compliance with a postal
faecal occult blood test. Aust N Z J Public Health. 1994;18(1):87–92.
29. Libby G, et al. Pre-notification increases uptake of colorectal cancer screening in all
demographic groups: a randomized controlled trial. J Med Screen. 2011;18(1):24–9.
30. Lo SH, et al. Preformulated implementation intentions to promote
colorectal cancer screening: a cluster-randomized trial. Health Psychol. 2014;
33(9):998–1002.
Goodwin et al. Systematic Reviews           (2019) 8:257 Page 10 of 11
31. McGregor LM, et al. Reducing the social gradient in uptake of the NHS
colorectal cancer screening programme using a narrative-based information
leaflet: a cluster-randomised trial. Gastroenterol Res Pract. 2016;2016.
32. Moss S, Mathews C, Day TJ, Smith S, Seaman HE, Snowball J, et al. Increased
uptake and improved outcomes of bowel cancer screening with a faecal
immunochemical test: Results from a pilot study within the national
screening programme in England. Gut. 2017;66(9):1631–44.
33. Myers RE, et al. Behavioral interventions to increase adherence in colorectal
cancer screening. Med Care. 1991;29(10):1039–50.
34. Neter E, Stein N, Barnett-Griness O, Rennert G, Hagoel L. From the bench to
public health: Population-level implementation intentions in colorectal
cancer screening. Am J Prev Med. 2014 Mar;46(3):273–80.
35. O'Carroll RE, et al. Anticipated regret to increase uptake of colorectal cancer
screening (ARTICS): a randomised controlled trial. Soc Sci Med. 2015;142:
118–27.
36. Robinson MHE, et al. Haemoccult screening for colorectal cancer: the effect
of dietary restriction on compliance. Eur J Surg Oncol. 1994;20(5):545–8.
37. Santare D, et al. Improving uptake of screening for colorectal cancer: a
study on invitation strategies and different test kit use. Eur J Gastroenterol
Hepatol. 2015;27(5):536–43.
38. Van Roon AHC, et al. Advance notification letters increase adherence in
colorectal cancer screening: a population-based randomized trial. Prev Med.
2011;52(6):448–51.
39. Van Rossum LG, et al. Random comparison of guaiac and immunochemical
fecal occult blood tests for colorectal cancer in a screening population.
Gastroenterology. 2008;135(1):82–90.
40. Verne J, et al. Self-administered faecal occult blood tests do not increase
compliance with screening for colorectal cancer: results of a randomized
controlled trial. Eur J Cancer Prev. 1993;2(4):301–5.
41. Wardle J, von Wagner C, Kralj-Hans I, Halloran SP, Smith SG, McGregor LM,
et al. Effects of evidence-based strategies to reduce the socioeconomic
gradient of uptake in the English NHS Bowel Cancer Screening Programme
(ASCEND): four cluster-randomised controlled trials. The Lancet. 2016;
387(10020):751–9.
42. Watson J, et al. Use of research questionnaires in the NHS bowel Cancer
screening Programme in England: impact on screening uptake. J Med
Screen. 2013;20(4):192–7.
43. White B, et al. Piloting the impact of three interventions on guaiac faecal
occult blood test uptake within the NHS bowel cancer screening
programme. Biomed Res Int. 2015;2015:1–11.
44. Zajac IT, et al. Endorsement by the primary care practitioner consistently
improves participation in screening for colorectal cancer: a longitudinal
analysis. J Med Screen. 2010;17(1):19–24.
45. Zubero MB, et al. Population-based colorectal cancer screening: comparison
of two fecal occult blood test. Front Pharmacol. 2014;4:175.
46. Hewitson P, et al. Primary care endorsement letter and a patient leaflet to
improve participation in colorectal cancer screening: results of a factorial
randomised trial. Br J Cancer. 2011;105(4):475–80.
47. Wardle J, et al. Effects of evidence-based strategies to reduce the
socioeconomic gradient of uptake in the English NHS bowel cancer
screening programme (ASCEND): four cluster-randomised controlled trials.
Lancet. 2016;387(10020):751–9.
48. Neter E, et al. From the bench to public health: population-level
implementation intentions in colorectal cancer screening. Am J Prev Med.
2014;46(3):273–80.
49. Arnold CL, et al. Final results of a 3-year literacy-informed intervention to
promote annual fecal occult blood test screening. J Community Health.
2016;41(4):724–31.
50. Moss S, Mathews C, Day TJ, Smith S, Seaman HE, Snowball J, Halloran SP.
Increased uptake and improved outcomes of bowel cancer screening with
a faecal immunochemical test: results from a pilot study within the national
screening programme in England. Gut. 2017;66(9):1631–44.
51. Coronado GD, et al. Effectiveness of a clinic-based colorectal cancer
screening promotion program for underserved Hispanics. Cancer. 2011;
117(8):1745–54.
52. Coronado GD, et al. Effect of reminding patients to complete fecal
immunochemical testing: a comparative effectiveness study of automated
and live approaches. J Gen Intern Med. 2018;33(1):72–8.
53. Hirst Y, et al. Text Reminders in Colorectal Cancer Screening (TRICCS):
Protocol for a randomised controlled trial. BMC Public Health. 2016;16(1):74.
54. Pennbridge J, Moya R, Rodrigues L. Questionnaire survey of California
consumers' use and rating of sources of health care information including
the internet. West J Med. 1999;171(5–6):302.
55. Närhi U. Sources of medicine information and their reliability evaluated by
medicine users. Pharm World Sci. 2007;29(6):688–94.
56. Khoo K, et al. Health information seeking by parents in the internet age. J
Paediatr Child Health. 2008;44(7–8):419–23.
57. Duffy SW, Myles JP, Maroni R, Mohammad A. Rapid review of evaluation of
interventions to improve participation in cancer screening services. J Med
Screen. 2017;24(3):127–145.
58. Reynolds LM, et al. Disgust and behavioral avoidance in colorectal cancer
screening and treatment: a systematic review and research agenda. Cancer
Nurs. 2013;36(2):122–30.
59. Schreuders EH, et al. Colorectal cancer screening: a global overview of
existing programmes. Gut. 2015;64(10):1637–49.
60. Rücker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on I 2 in
assessing heterogeneity may mislead. BMC Med Res Methodol. 2008;8(1):79.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Goodwin et al. Systematic Reviews           (2019) 8:257 Page 11 of 11
